Hormonal therapy plus radiation increases survival in node-positive prostate cancer

the ONA take:

According to a new study published online in the Journal of the National Cancer Institute, researchers from the American Cancer Society and Massachusetts General Hospital Cancer Center in Boston have found that the addition of radiotherapy to hormonal therapy may improve survival in men with node-positive prostate cancer who are at significant risk of cancer-related death.

The study showed that approximately half of patients with node-positive prostate cancer in the United States who had not received combined radiation therapy and hormonal therapy and were therefore not receiving the treatment that could best inhibit tumor growth and improve survival.

"Our analysis of a large national database revealed that adding radiation therapy to androgen-deprivation therapy decreased the risk of death in these patients by 50 percent over five years," says Jason Efstathiou, MD, DPhil, of the MGH Cancer Center and Department of Radiation Oncology, senior author of the study.

Researchers found that more aggressive local management of prostate cancer that is limited to the pelvis can result in more durable disease control, limit cancer metastasis, and potentially cure some patients.

Hormonal therapy plus radiation increases survival in node-positive prostate cancer
Addition of radiotherapy to hormonal therapy may improve survival in men with node-positive prostate cancer.
A new study finds that men with prostate cancer that has spread to nearby lymph nodes, who have a significant risk of dying from the disease, can benefit from the addition of radiation therapy to treatments that block the effects of testosterone.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs